HUTCHMED (China) (HCM) Curent Deferred Tax Liability (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Curent Deferred Tax Liability came in at $255000.0 in Q4 2025, down 90.59% on a QoQ basis from $2.7 million in Q4 2022.
HUTCHMED (China) (HCM) Curent Deferred Tax Liability (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 9 years of Curent Deferred Tax Liability data on file, last reported at $255000.0 in Q4 2025.
- On a quarterly basis, Curent Deferred Tax Liability changed N/A year-over-year to $255000.0 in Q4 2025; TTM through Dec 2025 was $255000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $255000.0, changed N/A from the prior year.
- Curent Deferred Tax Liability for Q4 2025 stood at $255000.0, down from $2.7 million in the prior quarter.
- Over the last five years, Curent Deferred Tax Liability for HCM reached as high as $2.8 million in Q4 2021 and fell as low as $255000.0 in Q4 2025.
- Historically, Curent Deferred Tax Liability has averaged $1.9 million across 3 years, with a median of $2.7 million in 2022.
- Across the five-year window, Curent Deferred Tax Liability sank 45.39% in 2021 and declined 1.99% in 2022, its largest moves.
- Year by year, Curent Deferred Tax Liability stood at $2.8 million in 2021, then fell by 1.99% to $2.7 million in 2022, then tumbled by 90.59% to $255000.0 in 2025.
- Per Business Quant data, the three most recent Curent Deferred Tax Liability figures were $255000.0 in Q4 2025, $2.7 million in Q4 2022, and $2.8 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 255,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 255,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Dec 31, 2022 | 2.71 Mn |
| Dec 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Dec 31, 2020 | 5.06 Mn |
| Dec 31, 2020 | 5.06 Mn |
| Dec 31, 2019 | 3.16 Mn |
| Dec 31, 2019 | 3.16 Mn |
| Dec 31, 2018 | 4.84 Mn |
| Dec 31, 2018 | 4.84 Mn |
| Jun 30, 2018 | 5.05 Mn |
| Jun 30, 2018 | 5.05 Mn |
| Dec 31, 2017 | 4.45 Mn |
| Dec 31, 2017 | 4.45 Mn |
| Dec 31, 2016 | 4.00 Mn |
| Dec 31, 2016 | 4.00 Mn |
| Jun 30, 2016 | 2.40 Mn |
| Jun 30, 2016 | 2.40 Mn |